THE ROLE OF NO SYNTHESIS CORRECTION IN PREVENTION OF CARDIOVASCULAR HYPERTENSIVE REMODELING

THE ROLE OF NO SYNTHESIS CORRECTION IN PREVENTION OF CARDIOVASCULAR HYPERTENSIVE REMODELING

Comparative study of preventive effects of two beta-blocking drugs with different mode of action was performed on SHRSP and WKY rats. Morphological and functional parameters – blood pressure, endothelium-dependent vascular relaxation, plasma level of nitric oxide stable metabolites (nitrite/nitrate)...

Full description

Bibliographic Details
Main Authors:	V. I. Buvaltsev, S. Y. Mashina, D. A. Pokidyshev, B. V. Smirin, L. A. Bayda, V. Y. Malyshev, E. B. Manukina
Format:	Article
Language:	Russian
Published:	«FIRMA «SILICEA» LLC 2002-10-01
Series:	Российский кардиологический журнал
Subjects:	arterial hypertension nebivolol nitriс oxide cardiovascular remodeling
Online Access:	https://russjcardiol.elpub.ru/jour/article/view/1906

Similar Items

Use of nebivolol in patients with mild and moderate hypertensive disease
by: L V Zhigunova, et al.
Published: (2003-03-01)

Nebivolol alleviates aortic remodeling through eNOS upregulation and inhibition of oxidative stress in l-NAME-induced hypertensive rats
by: Yan Wang, et al.
Published: (2017-10-01)

Beneficial Effects of Nebivolol in Comparison with Atenolol on Safety and Tolerability in Essential Hypertension
by: Vivek V. Bhosale, et al.
Published: (2014-06-01)

Endothelium dysfunction at arterial hypertension: focus on nebivolol
by: Nikolay Aleksandrovich Vaulin
Published: (2009-03-01)

Hypertension treatment: Is there a place for b-adrenoblockers?
by: L O Minushkina
Published: (2013-03-01)

Effects of nebivolol on artery hypertension--multicentre study Bosnia and Herzegovina
by: Zumreta Kušljugić, et al.
Published: (2005-02-01)

Spirapril effects on heart remodeling in patients with mild to moderate arterial hypertension
by: M. M. Beraya, et al.
Published: (2007-02-01)

The impact of obesity on the parameters of cardiovascular remodeling, cerebral blood flow and autonomic regulation of cardiac rhythm in hypertensive patients
by: V. V. Syvolap, et al.
Published: (2017-04-01)

HEMODYNAMIC AND METABOLIC EFFECTS OF NEBIVOLOL IN LOCOMOTIVE CREW STAFF WITH NEWLY DIAGNOSED ARTERIAL HYPERTENSION
by: I. V. Osipova, et al.
Published: (2016-01-01)

Cardiovascular remodeling and calcium-regulating function of parathyroid glands in arterial hypertension
by: B. G. Iskenderov, et al.
Published: (2007-04-01)

Arterial remodeling in older patients with arterial hypertension
by: A. V. Agafonov, et al.
Published: (2005-06-01)

Efficacy and Safety of Nebivolol and Rosuvastatin Combination Treatment in Patients with Concomitant Hypertension and Hyperlipidemia
by: Rhee MY, et al.
Published: (2020-11-01)

EFFECTS OF NEBIVOLOL VS NADOLOL ON GLUCOSE AND LIPID METABOLISM IN OVERWEIGHT HYPERTENSIVE PATIENTS. A OPEN RANDOMIZED CONTROLLED STUDY
by: E. R. Berngardt, et al.
Published: (2003-06-01)

Features of the pro-inflammatory activation and its role in the pathogenesis of cardiovascular remodeling in hypertensive patients of the ii nd stage
by: V. A. Vizir, et al.
Published: (2013-08-01)

SPECIAL PROPERTIES OF THE LEFT VENTRICLE MYOCARDUM REMODELING IN ATHLETES WITH ARTERIAL HYPERTENSION
by: N. V. Fomina, et al.
Published: (2015-04-01)

INDIVIDUAL, ABSOLUTE AND RELATIVE CARDIOVASCULAR RISK IN ELDERLY PATIENTS WITH ARTERIAL HYPERTENSION AND ITS DYNAMICS UNDER ANTIHYPERTENSIVE TREATMENT
by: B. A. Hapayev, et al.
Published: (2001-06-01)

Nebivolol for treatment patients with arterial hypertension
by: O M Mikheeva, et al.
Published: (2014-09-01)

PREDICTION ROLE OF THE LEFT VENTRICLE REMODELLING IN ARTERIAL HYPERTENSION PATIENTS
by: S. V. Ivanova, et al.
Published: (2016-12-01)

PREDICTION ROLE OF THE LEFT VENTRICLE REMODELLING IN ARTERIAL HYPERTENSION PATIENTS
by: S. V. Ivanova, et al.
Published: (2016-12-01)

Sirtuin-3-Mediated Cellular Metabolism Links Cardiovascular Remodeling with Hypertension
by: Jing Gao, et al.
Published: (2023-05-01)

Peculiarities of cardiovascular remodeling in hypertensive patients at high additional risk with concomitant subclinical hypothyroidism
by: V. V. Syvolap, et al.
Published: (2019-02-01)

The dynamics of 24-hour ambulatory blood pressure monitoring parameters, subclinical damage and endothelial function of vessels in patients with arterial hypertension and chronic obstructive pulmonary disease treated with S-amlodipine, Nebivolol and Enala
by: O. G. Ivanko, et al.
Published: (2017-02-01)

Left ventricular remodeling in patients with rheumatoid arthritis and arterial hypertension
by: T. Yu. Kasimova, et al.
Published: (2008-02-01)

EFFICACY AND SAFETY OF VASOACTIVE BETA-BLOCKERS IN ACUTE PHARMACOLOGICAL TEST IN HYPERTENSIVE PATIENTS OF DIFFERENT AGES
by: O. V. Fedorishina, et al.
Published: (2016-01-01)

Importance of hemodynamic factors in vascular remodeling of muscular elastic type in arterial hypertension
by: Melnikova L.V.
Published: (2011-03-01)

NEW METHODS OF ASSESSMENT OF SUBCLINICAL CHANGES IN THE CARDIOVASCULAR SYSTEM IN ARTERIAL HYPERTENSION
by: Zh. D. Kobalava, et al.
Published: (2016-06-01)

MODELING OF THE NITRIFICATION PROCESS IN A SOIL IN CĂLĂRAŞI COUNTY
by: Cecilia NEAGU
Published: (2015-04-01)

MODERN POTENTIAL IN THE TREATMENT OF METABOLIC SYNDROME PATIENTS - FOCUS ON ENDOTHELIUM
by: V. B. Mychka, et al.
Published: (2014-03-01)

AMLODIPINE ADVANTAGES IN ARTERIAL HYPERTENSION THERAPY
by: V. M. Tsareva, et al.
Published: (2016-01-01)

Combination antihypertensive therapy in patients with arterial hypertension and coronary heart disease
by: T. E. Morozova, et al.
Published: (2013-08-01)

Nebivolol And Quinapril Reduce P-Wave Duration And Dispersion In Hypertensive Patients
by: Hasan Korkmaz, et al.
Published: (2009-05-01)

Comparative analysis of the efficiency of the selective b-blocker nebivolol and the angiotensin II receptor blocker valsartan in men with hypertension, metabolic syndrome, and erectile dysfunction
by: S. V Nedogoda, et al.
Published: (2013-06-01)

NEBIVOLOL: A THIRD GENERATION BETA BLOCKER AS ANTIHYPERTENSION AGENT
by: Ni Putu Wirantari, et al.
Published: (2013-07-01)

Correlation of structure-geometrical cardiac remodeling and bone mineral density in essential arterial hypertension
by: N. Yu. Khosyainova, et al.
Published: (2007-04-01)

Relationship of left ventricular, elastic and muscular arteries remodeling in patients with uncontrolled arterial hypertension
by: S. Ya. Dotsenko, et al.
Published: (2013-04-01)

Left ventricular remodelling types in elderly patients with arterial hypertension
by: L. Kh. Gadzhieva, et al.
Published: (2013-02-01)

POSSIBILITY OF BONE METABOLISM MODULATOR (STRONTIUM RANELATE) USAGE FOR THE TREATMENT OF WOMEN WITH POSTMENOPAUSAL OSTEOPOROSIS AND ARTERIAL HYPERTENSION
by: N. J. Hozjainova, et al.
Published: (2016-01-01)

Risk of Hospitalization for Cardiovascular Events with β-Blockers in Hypertensive Patients: A Retrospective Cohort Study
by: Jan Basile, et al.
Published: (2018-09-01)

Influence of bisoprolol and nebivolol on the regulatory-adaptive status of patients with diastolic chronic heart failure
by: Pavel V. Khilkevich, et al.
Published: (2022-12-01)

Left ventricular remodeling and diastolic function in patients with arterial hypertension and rheumatoid arthritis
by: E. V. Arshin, et al.
Published: (2005-06-01)